Effects of Polymorphic DNA Genes Involved in BER and Caspase Pathways on the Clinical Outcome of Myeloproliferative Neoplasms Under Treatment With Hydroxyurea

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2018.9535
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative

American Journal of Hematology
Hematology
2019English

Myeloproliferative Neoplasms: Morphology and Clinical Practice

American Journal of Hematology
Hematology
2016English

1. Pathophysiology and Treatment Strategies of Myeloproliferative Neoplasms

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Targeting Myeloid Cells to Prevent Recurrent Stroke in General Population: The Lesson of Hydroxyurea in Myeloproliferative Neoplasms

Blood Cancer Journal
OncologyHematology
2018English

An Exciting New Era in the Treatment of Myeloproliferative Neoplasms

Oncology & Hematology Review (US)
2016English

Ruxolitinib Treatment and Risk of B‐cell Lymphomas in Myeloproliferative Neoplasms

American Journal of Hematology
Hematology
2019English

The Use of Anagrelide in Myeloproliferative Neoplasms, With Focus on Essential Thrombocythemia

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Effect of Mutation Order on Myeloproliferative Neoplasms

New England Journal of Medicine
Medicine
2015English

Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome

Clinical Medicine Insights: Case Reports
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy